Joel Lewis

President and CEO, Director, Galectin Therapeutics Inc

Bought, 12 months

$0.0M

Sold, 12 months

$0.6M

Companies

Latest trade

Jan 6, 2026

Companies

Galectin Therapeutics IncPresident and CEO, Director −$0.6M

Trades

GALT Sold 37,698 shares at $3.58 · planned $0.1M Jan 6

GALT Sold 27,731 shares at $3.91 · planned $0.1M Jan 5

GALT Sold 18,571 shares at $4.20 · planned $0.1M Jan 2

GALT Sold 7,829 shares at $7.06 · planned $0.1M Dec 17

GALT Sold 6,783 shares at $6.15 · planned $0.0M Nov 18

GALT Sold 15,680 shares at $6.04 · planned $0.1M Nov 17

GALT Sold 1,867 shares at $6.03 · planned $0.0M Nov 10

GALT Sold 200 shares at $6.00 · planned $0.0M Nov 5

GALT Sold 14,420 shares at $6.07 · planned $0.1M Nov 4

GALT Sold 1,300 shares at $6.01 · planned $0.0M Nov 3

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.